In breast cancer, ALKBH5 has been shown to promote tumourigenesis by decreasing adenosine methylation in KLF4 and NANOG mRNAs, enhancing their stability in breast cancer stem cells [135, 137]. The gene discussed is NANOG; the disease is breast cancer.